Basal insulin Toujeo® New Drug Application accepted

The U.S. Food and Drug Administration has accepted for review a New Drug Application for Toujeo® (insulin glargine [rDNA origin] injection, 300 U/ml), an investigational basal insulin.

Source: Pharmacy Europe - July 8, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Diabetes investigational basal insulin Latest News sanofi Toujeo Source Type: news